Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
Frick
Marie Antoinette
MA
Soler-Palacín
Pere
P
Martín Nalda
Andrea
A
Guarner
María Espiau
ME
Nadal
Concepció Figueras
CF
D000284:Administration, Oral; D000293:Adolescent; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D008297:Male; D009181:Mycoses / Q000188:drug therapy*; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole